TW360537B - Fatty acid derivatives - Google Patents
Fatty acid derivativesInfo
- Publication number
- TW360537B TW360537B TW084103055A TW84103055A TW360537B TW 360537 B TW360537 B TW 360537B TW 084103055 A TW084103055 A TW 084103055A TW 84103055 A TW84103055 A TW 84103055A TW 360537 B TW360537 B TW 360537B
- Authority
- TW
- Taiwan
- Prior art keywords
- fatty acid
- acid derivatives
- ascorbyl
- ascorbic
- gamma
- Prior art date
Links
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
- FLRQOWAOMJMSTP-JJTRIOAGSA-N [(2s)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] (6z,9z,12z)-octadeca-6,9,12-trienoate Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O FLRQOWAOMJMSTP-JJTRIOAGSA-N 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
- 229960002733 gamolenic acid Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Birds (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9403855A GB9403855D0 (en) | 1994-03-01 | 1994-03-01 | Fatty acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW360537B true TW360537B (en) | 1999-06-11 |
Family
ID=10751060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW084103055A TW360537B (en) | 1994-03-01 | 1995-03-30 | Fatty acid derivatives |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5847000A (zh) |
| EP (1) | EP0675120B1 (zh) |
| JP (1) | JPH07309753A (zh) |
| KR (1) | KR950031065A (zh) |
| CN (1) | CN1111508A (zh) |
| AT (1) | ATE208384T1 (zh) |
| AU (1) | AU703651B2 (zh) |
| CA (1) | CA2143603A1 (zh) |
| DE (1) | DE69523654T2 (zh) |
| DK (1) | DK0675120T3 (zh) |
| ES (1) | ES2167401T3 (zh) |
| FI (1) | FI950909A (zh) |
| GB (1) | GB9403855D0 (zh) |
| NO (1) | NO950784L (zh) |
| NZ (1) | NZ270575A (zh) |
| PT (1) | PT675120E (zh) |
| SG (1) | SG50339A1 (zh) |
| TW (1) | TW360537B (zh) |
| ZA (1) | ZA951505B (zh) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7138431B1 (en) * | 1998-02-23 | 2006-11-21 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| GB0111282D0 (en) * | 2001-05-09 | 2001-06-27 | Laxdale Ltd | Potentiation of therapeutic effects of fatty acids |
| CA2449199A1 (en) * | 2001-05-30 | 2002-12-05 | Laxdale Limited | Coenzyme q and eicosapentaenoic acid (epa) |
| JP3847693B2 (ja) * | 2002-09-30 | 2006-11-22 | シャープ株式会社 | 半導体装置の製造方法 |
| WO2004068970A2 (en) * | 2003-01-31 | 2004-08-19 | The Procter & Gamble Company | Means for improving the appearance of mammalian keratinous tissue |
| US20050123500A1 (en) * | 2003-01-31 | 2005-06-09 | The Procter & Gamble Company | Means for improving the appearance of mammalian hair and nails |
| EP1620419A4 (en) * | 2003-04-21 | 2008-07-23 | Tagra Biotechnologies Ltd | STABILIZED DERIVATIVES OF ASCORBIC ACID |
| CA2436650A1 (en) * | 2003-08-06 | 2005-02-06 | Naturia Inc. | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
| JP2006056795A (ja) * | 2004-08-18 | 2006-03-02 | Suntory Ltd | ６−ｏ−ｐｕｆａアスコルビン酸エステルを含有する皮膚化粧料並びに飲食品 |
| GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| AU2011349718B2 (en) * | 2010-12-21 | 2017-02-09 | Nestec S.A. | Methods and compositions for preventing and treating osteoarthritis |
| US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
| US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
| US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
| JPWO2012153832A1 (ja) | 2011-05-12 | 2014-07-31 | 日本水産株式会社 | 炎症性疾患用皮膚外用組成物 |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| JP6824038B2 (ja) | 2013-12-04 | 2021-02-03 | 日本水産株式会社 | ジホモ−γ−リノレン酸含有微生物油及びジホモ−γ−リノレン酸含有微生物菌体 |
| JP5792330B2 (ja) * | 2014-01-27 | 2015-10-07 | サントリーホールディングス株式会社 | ６−ｏ−ｐｕｆａアスコルビン酸エステルを含有する皮膚化粧料並びに飲食品 |
| KR102391827B1 (ko) | 2014-06-04 | 2022-04-27 | 디에스 바이오파마 리미티드 | Dgla를 포함하는 약제학적 조성물 및 그의 용도 |
| US10639313B2 (en) | 2017-09-01 | 2020-05-05 | Ndsu Research Foundation | Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE639776C (de) * | 1934-06-12 | 1936-12-12 | Hoffmanni La Roche & Co Akt Ge | Verfahren zur Darstellung von Verbindungen der Ascorbinsaeure |
| CH339632A (de) * | 1955-07-07 | 1959-07-15 | Uni Chemie Ag | Verfahren zur Darstellung von Verbindungen mit Vitamin-C- und -F-Wirkung |
| BE639828A (zh) * | 1962-11-14 | |||
| DE1231848B (de) * | 1965-04-15 | 1967-01-05 | Thomae Gmbh Dr K | Verfahren zur Herstellung von stabilen Vitamin-C-haltigen Tabletten |
| CH631451A5 (de) * | 1976-10-05 | 1982-08-13 | Univ Kansas State | Verfahren zur herstellung von fettsaeureester der ascorbinsaeure. |
| GB1580444A (en) * | 1976-11-04 | 1980-12-03 | Bio Oil Res | Pharmaceutical compositions |
| US4289702A (en) * | 1977-12-16 | 1981-09-15 | Pfizer Inc. | Preparation of erythorbic acid and ascorbis acid 6-fatty acid esters |
| IE49783B1 (en) * | 1979-05-18 | 1985-12-11 | Efamol Ltd | Pharmaceutical and dietary composition comprising epsilon-linolenic acids |
| IE53332B1 (en) * | 1980-03-14 | 1988-10-26 | Efamol Ltd | Pharmaceutical compositions |
| ATE22804T1 (de) * | 1982-03-01 | 1986-11-15 | Efamol Ltd | Pharmazeutische zusammensetzung. |
| AU1933383A (en) * | 1982-09-22 | 1984-03-29 | Sentrachem Limited | Composition of prostaglandins for prevention of cancer |
| GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
| DE3308922A1 (de) * | 1983-03-12 | 1984-09-13 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von fettsaeureestern der ascorbinsaeure |
| JPS59199636A (ja) * | 1983-04-26 | 1984-11-12 | Nippon Mejifuijitsukusu Kk | 放射性診断剤 |
| ATE55905T1 (de) * | 1984-03-07 | 1990-09-15 | Roshdy Ismail | Mittel zur behandlung und zum schutz der haut. |
| US4818521A (en) * | 1985-04-18 | 1989-04-04 | Sunstar Kabushiki Kaisha | Emulsion cosmetic stably containing vitamin C |
| US4792418A (en) * | 1985-08-14 | 1988-12-20 | Century Laboratories, Inc. | Method of extraction and purification of polyunsaturated fatty acids from natural sources |
| US4822898A (en) * | 1985-09-20 | 1989-04-18 | Sumitomo Chemical Company, Limited | Ascorbic acid or erythorbic acid derivatives |
| JPS6281307A (ja) * | 1985-10-04 | 1987-04-14 | Kanebo Ltd | 皮膚化粧料 |
| JP2869650B2 (ja) * | 1987-05-15 | 1999-03-10 | チッソ株式会社 | 光学活性化合物およびその製造方法 |
| DK291588A (da) * | 1987-06-26 | 1988-12-27 | Hoffmann La Roche | Fremgangsmaade til fremstilling af ascorbinsyre-6-estere |
| JPH0818963B2 (ja) * | 1987-09-28 | 1996-02-28 | サンスター株式会社 | 美白化粧料 |
| DE3820693A1 (de) * | 1988-06-18 | 1989-12-21 | Henkel Kgaa | Topische kosmetische und pharmazeutische zubereitungen |
| US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
| DE69019779T2 (de) * | 1989-05-19 | 1995-12-14 | Hayashibara Biochem Lab | Alpha-Glycosyl-L-ascorbinsäure und ihre Herstellung und Verwendungen. |
| US5079153A (en) * | 1989-06-03 | 1992-01-07 | Mitsubishi Rayon Co., Ltd. | Process for the preparation of organic esters of ascorbic acid or erythorbic acid using ester hydralases in organic solvents containing 100-10,000 ppm of water |
| JP2831395B2 (ja) * | 1989-09-12 | 1998-12-02 | ハリマ化成株式会社 | アスコルビン酸エステル |
| US5122536A (en) * | 1989-10-12 | 1992-06-16 | Perricone Nicholas V | Method for the topical treatment of psoriasis |
| US5574063A (en) * | 1989-10-12 | 1996-11-12 | Perricone; Nicholas V. | Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage |
| GB9001121D0 (en) * | 1990-01-18 | 1990-03-21 | Efamol Holdings | Efa compositions and therapy |
| US5078989A (en) * | 1990-03-28 | 1992-01-07 | Sunstar K.K. | Skin whitening cosmetics |
| JPH05209968A (ja) * | 1990-12-28 | 1993-08-20 | Hamamatsu Photonics Kk | 放射線検出装置 |
| GB9111900D0 (en) * | 1991-06-03 | 1991-07-24 | Efamol Holdings | Fatty acid compositions |
| DE4133694C2 (de) * | 1991-10-11 | 1993-10-07 | Fresenius Ag | Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen |
| JPH05219970A (ja) * | 1992-02-10 | 1993-08-31 | Mitsubishi Rayon Co Ltd | 有機酸エステルの製造法 |
| GB9213322D0 (en) * | 1992-06-23 | 1992-08-05 | Efamol Holdings | Antioxidant compositions |
| GB9217780D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| US5516793A (en) * | 1993-04-26 | 1996-05-14 | Avon Products, Inc. | Use of ascorbic acid to reduce irritation of topically applied active ingredients |
| ES2158084T3 (es) * | 1994-02-04 | 2001-09-01 | Lipocore Holding Ab | Preparaciones vehiculo lipofilicas. |
| AU711482B2 (en) * | 1994-06-28 | 1999-10-14 | Scotia Holdings Plc | Compositions for treatment of diabetic complications |
-
1994
- 1994-03-01 GB GB9403855A patent/GB9403855D0/en active Pending
-
1995
- 1995-02-22 AU AU13408/95A patent/AU703651B2/en not_active Ceased
- 1995-02-23 ZA ZA951505A patent/ZA951505B/xx unknown
- 1995-02-24 JP JP7037258A patent/JPH07309753A/ja active Pending
- 1995-02-27 NZ NZ270575A patent/NZ270575A/en unknown
- 1995-02-28 NO NO950784A patent/NO950784L/no not_active Application Discontinuation
- 1995-02-28 SG SG1995000051A patent/SG50339A1/en unknown
- 1995-02-28 CA CA002143603A patent/CA2143603A1/en not_active Abandoned
- 1995-02-28 FI FI950909A patent/FI950909A/fi not_active Application Discontinuation
- 1995-03-01 EP EP95301316A patent/EP0675120B1/en not_active Expired - Lifetime
- 1995-03-01 DK DK95301316T patent/DK0675120T3/da active
- 1995-03-01 DE DE69523654T patent/DE69523654T2/de not_active Expired - Fee Related
- 1995-03-01 CN CN95102756A patent/CN1111508A/zh active Pending
- 1995-03-01 ES ES95301316T patent/ES2167401T3/es not_active Expired - Lifetime
- 1995-03-01 AT AT95301316T patent/ATE208384T1/de not_active IP Right Cessation
- 1995-03-01 PT PT95301316T patent/PT675120E/pt unknown
- 1995-03-02 KR KR1019950004287A patent/KR950031065A/ko not_active Application Discontinuation
- 1995-03-30 TW TW084103055A patent/TW360537B/zh active
-
1997
- 1997-03-28 US US08/828,716 patent/US5847000A/en not_active Expired - Fee Related
-
1998
- 1998-03-02 US US09/034,029 patent/US6177470B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07309753A (ja) | 1995-11-28 |
| NO950784D0 (no) | 1995-02-28 |
| AU1340895A (en) | 1995-09-07 |
| FI950909A0 (fi) | 1995-02-28 |
| FI950909A (fi) | 1995-09-02 |
| NO950784L (no) | 1995-09-04 |
| CA2143603A1 (en) | 1995-09-02 |
| AU703651B2 (en) | 1999-04-01 |
| ATE208384T1 (de) | 2001-11-15 |
| ES2167401T3 (es) | 2002-05-16 |
| EP0675120A2 (en) | 1995-10-04 |
| CN1111508A (zh) | 1995-11-15 |
| DE69523654D1 (de) | 2001-12-13 |
| PT675120E (pt) | 2002-04-29 |
| ZA951505B (en) | 1995-12-08 |
| US6177470B1 (en) | 2001-01-23 |
| US5847000A (en) | 1998-12-08 |
| EP0675120B1 (en) | 2001-11-07 |
| NZ270575A (en) | 1998-08-26 |
| SG50339A1 (en) | 1998-07-20 |
| DE69523654T2 (de) | 2002-08-01 |
| GB9403855D0 (en) | 1994-04-20 |
| EP0675120A3 (en) | 1998-07-08 |
| KR950031065A (ko) | 1995-12-18 |
| DK0675120T3 (da) | 2002-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW360537B (en) | Fatty acid derivatives | |
| MY110110A (en) | Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders | |
| AU2685088A (en) | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract | |
| IE821214L (en) | Medicament | |
| NZ250583A (en) | Pharmaceutical, nutritional, or skin care compositions containing an ester of a cholesterol and fatty acid | |
| EP0513702A3 (en) | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | |
| AU4180593A (en) | The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura | |
| HUP9901707A3 (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders | |
| EG17609A (en) | Process for preparation of therapeutic agents from derivatives of propoimic acid. | |
| AU1968992A (en) | Preparation of fatty acid medicaments | |
| CA2158036A1 (en) | 3,4-Diarylchromans for Treatment of Dermatitis | |
| AU4477893A (en) | Use of C1-inactivator for the production of a pharmaceutical for the prophylaxis and therapy of certain diseases | |
| EP0315113A3 (en) | Inner esters of gangliosides with analgesic-antiinflammatory activity | |
| CA2004332A1 (en) | Inhibition of cell adhesion | |
| CY1966A (en) | Diamine salts of clavulanic acid | |
| AU1956092A (en) | Pharmaceutical agent for treatment of withdrawal symptoms | |
| CA2108794A1 (en) | Use of torasemide for the treatment of brain oedemas | |
| HUT49053A (en) | Process for producing pharmaceutical composition comprising comt inhibitor as active ingredient and having action on gastrointestinal tract | |
| AU2968792A (en) | Method of preventing reocclusion of arteries | |
| AU574978B2 (en) | Method for treatment of antidiuresis employing serine derivatives | |
| AU4480693A (en) | Method for the safe administration of fatty acid | |
| IL105229A0 (en) | The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters as medicaments | |
| CA2133563A1 (en) | Use of hydriodic acid as an aphrodisiac | |
| CA2101548A1 (en) | Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases | |
| EP0345883A3 (en) | Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine |